Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on the Pharmacokinetics of DS-8500a in Japanese Healthy Subjects
jRCT2080223244Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of firuglipel in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Pharmacokinetic parameters of DS-8500a under fed and fasted conditions.
02
Drugs
firuglipel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080223244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223244.